Wall Street analysts expect that UroGen Pharma Ltd. (NASDAQ:URGN) will announce $8.41 million in sales for the current fiscal quarter, according to Zacks. Five analysts have provided estimates for UroGen Pharma’s earnings. The highest sales estimate is $11.50 million and the lowest is $4.00 million. The business is expected to announce its next quarterly earnings […]
